Larvol Delta - Results-of-ALLEVIATE-1-and-ALLEVIATE-2-Phase-3-trials-of-cebranopadol-a-firstinclass-dual-NOPMOP-receptor-agonist-for-the-treatment-of-acute-pain-after-abdominoplasty-and-bunionectomy

cebranopadol (TRN-228) - Tris Pharma

https://epostersonline.com/asraspring2026/node/1998

Todd Bertoch; Megan Shram; James Hackworth; Joseph Grieco; Harold Minkowitz

Apr 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next